Format

Send to

Choose Destination
J Mol Endocrinol. 2017 Oct;59(3):191-204. doi: 10.1530/JME-17-0014. Epub 2017 May 17.

Berberine reduced blood pressure and improved vasodilation in diabetic rats.

Author information

1
Department of OncologyThe Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
2
Department of Aerospace PhysiologyKey Laboratory of Aerospace Medicine of Ministry of Education, Fourth Military Medical University, Xi'an, Shaanxi Province, China manjiangxie@hotmail.com wangzhongwei601@163.com.
3
Department of OncologyThe Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China manjiangxie@hotmail.com wangzhongwei601@163.com.

Abstract

Hyperglycemia and hypertension are considered to be the two leading risk factors for vascular disease in diabetic patients. However, few pharmacologic agents could provide a combinational therapy for controlling hyperglycemia and hypertension at the same time in diabetes. The objectives of this study are to investigate whether berberine treatment could directly reduce blood pressure and identify the molecular mechanism underlying the vascular protection of berberine in diabetic rats. Berberine was intragastrically administered with different dosages of 50, 100 and 200 mg/kg/day to diabetic rats for 8 weeks since the injection of streptozotocin. The endothelium-dependent/-independent relaxation in middle cerebral arteries was investigated. The activity of large-conductance Ca2+-activated K+ channel (BKCa) was investigated by recording whole-cell currents, analyzing single-channel activities and assessing the expressions of α- and β1-subunit at protein or mRNA levels. Results of the study suggest that chronic administration of 100 mg/kg/day berberine not only lowered blood glucose but also reduced blood pressure and improved vasodilation in diabetic rats. Furthermore, berberine markedly increased the function and expression of BKCa β1-subunit in cerebral vascular smooth muscle cells (VSMCs) isolated from diabetic rats or when exposed to hyperglycemia condition. The present study provided initial evidences that berberine reduced blood pressure and improved vasodilation in diabetic rats by activation of BKCa channel in VSMCs, which suggested that berberine might provide a combinational therapy for controlling hyperglycemia and blood pressure in diabetes. Furthermore, our work indicated that activation of BKCa channel might be the underlying mechanism responsible for the vascular protection of berberine in diabetes.

KEYWORDS:

berberine; large-conductance calcium-activated K+ channel (BKCa); relaxation; vascular smooth muscle cells (VSMCs)

PMID:
28515053
DOI:
10.1530/JME-17-0014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center